The development of the nutrition and health industry is inseparable from the continuous progress of scientific research and the continuous promotion of scientific research results. 健合集团 As a global leader in the nutrition and health industry, its brand 合生元 has persisted in the unremitting exploration of breast milk nutrition since its establishment, promoted the improvement and development of scientific research platforms and scientific research teams, and continuously introduced high-quality products. At the same time as nutritional products, its high-level scientific research results have also attracted attention from inside and outside the industry and are widely recognized. Recently, the latest research results of the functional protein that Synbiotics has been dedicated to researching for a long time-lactontin LPN appeared on the top international children's magazine SCI.
H&H Group was recognized again, and lactononin LPN was listed in the international authoritative pediatric journal
International authoritative pediatric LP3 journal publication _pspan7p As an international authoritative pediatric journal included in SCI, "Translational Pediatrics" published an English SCI article about lactopontin LPN-"A literature review on lactopontin and its roles in early life" Research Progress on Early Developmental Effects)", the main authors are Professor Tong Xiaomei, Director of Pediatrics Department of Peking University Third Hospital, and Professor Yu Huanling, Associate Dean of School of Public Health, Capital Medical University.
The article pointed out that lactonectin LPN is a key immunologically active protein in breast milk and has an important effect on the early development of infants and young children. He also made a number of research reports on the special role of lactontin LPN in infants’ early immune regulation, intestinal development, and nervous system development:
Health Heal Group was recognized again,The research results of lactonectin LPN have been empirically confirmed.
2. Lactontin LPN helps to promote the development and regulation of the immune system.
3. Clinical studies have shown that lactontin LPN can effectively reduce the probability of fever in infants and young children.
4. LPN LPN has the potential to promote the development of preterm infants.
The industry believes that with the continuous deepening of research on the active functional components of breast milk, the interaction and synergistic effects between biologically active components have also received more and more attention. It is for understanding the far-reaching benefits of breastfeeding and how to improve infant health. The situation is of great significance. The authoritative research progress of lactonopontin LPN has further scientifically demonstrated the scientific influence and professional image of the Biostime brand.
Pour into scientific research and innovation to boost the maternal and child nutrition and health industry
"Make people healthier and happier" is the mission that Jianhe Group has always adhered to. With the continuous increase in scientific research investment, Jianhe Group has improved In recent years, gratifying results have been achieved one after another. Since 2014, the Biostime Institute of Nutrition and Nursing (BINC) has in-depth cooperation with high-end R&D institutions such as Chinese Academy of Sciences and China Centers for Disease Control and Prevention to promote the integrated development of "production, learning, and research" in the nutrition and health industry. As of this year, Biostime has published 24 SCI scientific and technological papers, 27 Chinese scientific and technological papers, and applied for 23 invention patents in areas such as intestinal microecology, allergies, and brain-gut axis.
Related products of the Biostime brand under Health Hehe Group
Looking to the future,Jianhe Group will continue to adhere to the PPAE business model of Premium (high-end quality), Proven (scientific verification), Aspirational (aspirational, pursuit of excellence), and Engaging (participation in interaction), continue to cultivate quality and create high-end choices. We will also continue to pay attention to the latest developments in maternal and child health research, and work with experts and scholars in various fields to use the most advanced scientific strength to help the healthy development of the maternal and child industry.
.-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-